Role of hTERT rs2736100 in pathological scarring

  • Authors:
    • Roxana Flavia Ilieș
    • Salomea-Ruth Halmagyi
    • Andreea Cătană
    • Casian Simon Aioanei
    • Istvan Lukacs
    • Reka-Eniko Tokes
    • Ioana Cristina Rotar
    • Ioan Victor Pop
  • View Affiliations

  • Published online on: February 4, 2022     https://doi.org/10.3892/etm.2022.11186
  • Article Number: 260
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Hypertrophic and atrophic scars are the effect of a dysregulated wound‑healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family history. Recent studies have identified telomere shortening and decreased hTERT activity in pathological scarring, proposing the rs2736100 variant of human telomerase reverse transcriptase (hTERT) gene as a valuable variant gene candidate. We examined the scarring process in 71 female patients who had undergone Caesarean section and developed hypertrophic and atrophic scars with the objective to investigate the role of single nucleotide polymorphism (SNP) rs2736100 in pathological scarring. Genotyping was performed using RT‑PCR and follow‑up included the Patient Observer Scar Assessment Scale (POSAS) and SCAR scales. Comparative analysis for mean POSAS value between the check‑ups at 3 and 6 months revealed a statistical decreased difference of 1.71 points [95% confidence interval (CI), 0.4‑2.89; P=0.01], while SCAR highlighted a decreased difference of 0.670 (95% CI, ‑0.04‑1.38; P=0.055). The C variant allele revealed a borderline statistical value for the risk of developing pathological scarring (OR=1.44; 95% CI, 0.876‑1.332: P=0.066). In our study a pre‑conceptional body mass index (BMI) >25 kg/m2 was statistically associated with pathological scarring. The Fitzpatrick type 4 phototype displayed an increased frequency for the heterozygous genotype in the current study, and it was demonstrated that dark skin tone was associated with abnormal scar formation. Our study investigated the role of hTERT gene variant rs2736100 in hypertrophic and atrophic scarring in a Caucasian population group. We report a borderline statistically significant value for the variant C allele of hTERT SNP for the risk of developing pathological scarring in female patients that had undergone Caesarean section.
View References

Related Articles

Journal Cover

April-2022
Volume 23 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ilieș RF, Halmagyi S, Cătană A, Aioanei CS, Lukacs I, Tokes R, Rotar IC and Pop IV: Role of <em>hTERT</em> rs2736100 in pathological scarring. Exp Ther Med 23: 260, 2022.
APA
Ilieș, R.F., Halmagyi, S., Cătană, A., Aioanei, C.S., Lukacs, I., Tokes, R. ... Pop, I.V. (2022). Role of <em>hTERT</em> rs2736100 in pathological scarring. Experimental and Therapeutic Medicine, 23, 260. https://doi.org/10.3892/etm.2022.11186
MLA
Ilieș, R. F., Halmagyi, S., Cătană, A., Aioanei, C. S., Lukacs, I., Tokes, R., Rotar, I. C., Pop, I. V."Role of <em>hTERT</em> rs2736100 in pathological scarring". Experimental and Therapeutic Medicine 23.4 (2022): 260.
Chicago
Ilieș, R. F., Halmagyi, S., Cătană, A., Aioanei, C. S., Lukacs, I., Tokes, R., Rotar, I. C., Pop, I. V."Role of <em>hTERT</em> rs2736100 in pathological scarring". Experimental and Therapeutic Medicine 23, no. 4 (2022): 260. https://doi.org/10.3892/etm.2022.11186